Apyx Medical (NASDAQ:APYX) Trading 3.6% Higher – Here’s What Happened

Shares of Apyx Medical Co. (NASDAQ:APYX) traded up 3.6% during trading on Monday . The stock traded as high as $1.77 and last traded at $1.72. 30,375 shares changed hands during mid-day trading, a decline of 47% from the average session volume of 57,758 shares. The stock had previously closed at $1.66.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. BTIG Research initiated coverage on shares of Apyx Medical in a report on Thursday, October 17th. They set a “neutral” rating for the company. JMP Securities reissued a “market perform” rating on shares of Apyx Medical in a research note on Monday, September 16th. Finally, Craig Hallum raised shares of Apyx Medical to a “strong-buy” rating in a research report on Thursday, October 24th.

Apyx Medical Stock Performance

The company has a debt-to-equity ratio of 3.03, a current ratio of 5.46 and a quick ratio of 4.52. The stock has a fifty day simple moving average of $1.51 and a two-hundred day simple moving average of $1.35. The firm has a market capitalization of $64.75 million, a P/E ratio of -2.07 and a beta of 1.26.

Apyx Medical (NASDAQ:APYX) last released its quarterly earnings data on Friday, November 8th. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.01. Apyx Medical had a negative net margin of 58.59% and a negative return on equity of 137.98%. The company had revenue of $11.49 million during the quarter, compared to analyst estimates of $11.66 million. During the same quarter in the previous year, the business posted ($0.13) EPS. On average, research analysts predict that Apyx Medical Co. will post -0.68 EPS for the current year.

Institutional Trading of Apyx Medical

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Royce & Associates LP grew its holdings in shares of Apyx Medical by 3.4% during the third quarter. Royce & Associates LP now owns 2,582,490 shares of the company’s stock valued at $3,202,000 after buying an additional 85,267 shares during the last quarter. Commonwealth Equity Services LLC lifted its position in Apyx Medical by 2.9% in the 2nd quarter. Commonwealth Equity Services LLC now owns 511,561 shares of the company’s stock valued at $685,000 after acquiring an additional 14,481 shares in the last quarter. Private Advisor Group LLC boosted its stake in Apyx Medical by 3.9% during the 3rd quarter. Private Advisor Group LLC now owns 322,321 shares of the company’s stock valued at $400,000 after purchasing an additional 12,180 shares during the last quarter. Rathbones Group PLC boosted its stake in Apyx Medical by 148.0% during the 2nd quarter. Rathbones Group PLC now owns 251,334 shares of the company’s stock valued at $337,000 after purchasing an additional 150,000 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC bought a new stake in Apyx Medical during the 2nd quarter worth approximately $101,000. Institutional investors own 55.33% of the company’s stock.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.